News

As the early move on early arrival at Aspire 400 is fleshed out, Genesis will increasingly be rated as a high-growth gold ...
As the early move on early arrival at Aspire 400 is fleshed out, Genesis will increasingly be rated as a high-growth gold ...
Marc Raab, MD, PhD, discussed the MajesTEC-5 trial of teclistamab plus standard myeloma therapies in transplant-eligible newly diagnosed multiple myeloma.
You don't need to pay for a streaming service to watch a sky full of shooting stars. Here's a look at the year ahead in ...
If it feels like the global economy is burning that could be a hint that gold equities are about to outperform again.
There’s been a lack of constructive criticism and alternate agendas to President Donald Trump's plans from the Democratic ...